From Bio Co.,Ltd (KOSDAQ:377220)
South Korea · Delayed Price · Currency is KRW 1,260.00
+10.00 (0.80%)
At close: Feb 27, 2026
From Bio Co.,Ltd Market Cap
From Bio Co.,Ltd has a market cap or net worth of 35.67 billion as of February 27, 2026. Its market cap has decreased by -38.83% in one year.
Market Cap
35.67B
Enterprise Value
64.58B
Revenue
70.07B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,260.00
Market Cap Chart
Since September 28, 2021, From Bio Co.,Ltd's market cap has decreased from 274.62B to 35.67B, a decrease of -87.01%. That is a compound annual growth rate of -36.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 35.67B | 2.02% |
| Dec 30, 2025 | 34.96B | -33.24% |
| Dec 30, 2024 | 52.37B | -39.74% |
| Dec 28, 2023 | 86.91B | -26.64% |
| Dec 29, 2022 | 118.48B | -23.21% |
| Dec 30, 2021 | 154.29B | -43.82% |
| Sep 28, 2021 | 274.62B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Finemedix | 35.68B |
| SAWNICS | 35.65B |
| ES Cube | 35.63B |
| K3I.Co.,Ltd. | 35.60B |
| Castec Korea Co.,Ltd | 35.59B |
| Kainos Medicine | 35.56B |
| Eutilex.Co.,Ltd | 35.32B |
| INCON | 35.16B |